Highlights
IIA supported (ever)
About
Revolutionizing Skin Tumor Resection
The company is at the forefront of advancing melanoma cancer treatment by integrating state-of-the-art diagnostic methods and digital pathology. Its unique approach is aimed at achieving complete eradication of melanoma through a singular surgical procedure. By studying the functional properties of melanoma, the company aims to enhance treatment outcomes and potentially expand these methods to other types of skin tumors. Committed to advancing medical knowledge, the company is dedicated to reshaping the landscape of skin cancer treatment and making a lasting impact on patients' lives.
Identity
| Name | 2C3D |
|---|---|
| Slug | 2c3d |
| Former names | Skin Sight |
| Type / kind | startup |
| Source _id | bgntFfk19tW0anTCfbC1YRGGDiNQVHAuPnS6EXkeyUXvznXPvG2omg |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ address | Israel |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical DiagnosticsMedical DevicesDiagnostics Devices
Technologies
Artificial Intelligence
Target customers
Healthcare & Life SciencesMedical Devices IndustryMedical ProductsHealthcarePatients
Business models
B2B2CB2B
Tags
cancercancer-research
Funding
| Total raised | $40K |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}